Evidence suggests a strong association between depression, anxiety, cachexia, and high levels of cytokines expression (IL-1β, IL-6, IL-10, TNF-α, INF-γ, and fractalkine [CX3X]) in cancer patients [14]. This evidence concerns the gene IL1B and depressive symptom measurement.